Literature DB >> 20461491

Staging bipolar disorder.

Eduard Vieta1, M Reinares, A R Rosa.   

Abstract

The purpose of this study was to analyze the evidence supporting a staging model for bipolar disorder. The authors conducted an extensive Medline and Pubmed search of the published literature using a variety of search terms (staging, bipolar disorder, early intervention) to find relevant articles, which were reviewed in detail. Only recently specific proposals have been made to apply clinical staging to bipolar disorder. The staging model in bipolar disorder suggests a progression from prodromal (at-risk) to more severe and refractory presentations (Stage IV). A staging model implies a longitudinal appraisal of different aspects: clinical variables, such as number of episodes and subsyndromal symptoms, functional and cognitive impairment, comorbidity, biomarkers, and neuroanatomical changes. Staging models are based on the fact that response to treatment is generally better when it is introduced early in the course of the illness. It assumes that earlier stages have better prognosis and require simpler therapeutic regimens. Staging may assist in bipolar disorder treatment planning and prognosis, and emphasize the importance of early intervention. Further research is required in this exciting and novel area.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461491     DOI: 10.1007/s12640-010-9197-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  57 in total

1.  Early onset of lithium prophylaxis as a predictor of good long-term outcome.

Authors:  L Franchini; R Zanardi; E Smeraldi; M Gasperini
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

2.  Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry.

Authors:  Patrick D McGorry
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

3.  Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study.

Authors:  Hilary P Blumberg; John H Krystal; Ravi Bansal; Andrés Martin; James Dziura; Kathleen Durkin; Laura Martin; Elizabeth Gerard; Dennis S Charney; Bradley S Peterson
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

4.  Cerebral white matter lesions in bipolar affective disorder: relationship to outcome.

Authors:  P B Moore; D J Shepherd; D Eccleston; I C Macmillan; U Goswami; V L McAllister; I N Ferrier
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

5.  Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Authors:  Terence A Ketter; John P Houston; David H Adams; Richard C Risser; Adam L Meyers; Douglas J Williamson; Mauricio Tohen
Journal:  J Clin Psychiatry       Date:  2006-01       Impact factor: 4.384

Review 6.  Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives.

Authors:  Michael Berk; Gin S Malhi; Karen Hallam; Clarissa S Gama; Seetal Dodd; Ana Cristina Andreazza; Benício N Frey; Flavio Kapczinski
Journal:  J Affect Disord       Date:  2008-09-26       Impact factor: 4.839

Review 7.  Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence.

Authors:  Lucy J Robinson; I Nicol Ferrier
Journal:  Bipolar Disord       Date:  2006-04       Impact factor: 6.744

Review 8.  Early intervention in bipolar disorder, part I: clinical and imaging findings.

Authors:  Giacomo Salvadore; Wayne C Drevets; Ioline D Henter; Carlos A Zarate; Husseini K Manji
Journal:  Early Interv Psychiatry       Date:  2008-08       Impact factor: 2.732

9.  Early stages in the development of bipolar disorder.

Authors:  Anne Duffy; Martin Alda; Tomas Hajek; Simon B Sherry; Paul Grof
Journal:  J Affect Disord       Date:  2009-06-21       Impact factor: 4.839

10.  The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective.

Authors:  L V Kessing; M G Hansen; P K Andersen; J Angst
Journal:  Acta Psychiatr Scand       Date:  2004-05       Impact factor: 6.392

View more
  19 in total

1.  Cognitive deficits in first-degree relatives of bipolar patients: the use of homogeneous subgroups in the search of cognitive endophenotypes.

Authors:  Julia Volkert; J Haubner; J Kazmaier; F Glaser; J Kopf; S Kittel-Schneider; A Reif
Journal:  J Neural Transm (Vienna)       Date:  2016-06-08       Impact factor: 3.575

Review 2.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

3.  Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed?

Authors:  Anna R Van Meter; Eric A Youngstrom
Journal:  Neuropsychiatry (London)       Date:  2012-12-01

4.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

5.  Transdiagnostic clinical staging in youth mental health: a first international consensus statement.

Authors:  Jai L Shah; Jan Scott; Patrick D McGorry; Shane P M Cross; Matcheri S Keshavan; Barnaby Nelson; Stephen J Wood; Steven Marwaha; Alison R Yung; Elizabeth M Scott; Dost Öngür; Philippe Conus; Chantal Henry; Ian B Hickie
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

6.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 7.  Can bipolar disorder be viewed as a multi-system inflammatory disease?

Authors:  Marion Leboyer; Isabella Soreca; Jan Scott; Mark Frye; Chantal Henry; Ryad Tamouza; David J Kupfer
Journal:  J Affect Disord       Date:  2012-04-11       Impact factor: 4.839

Review 8.  Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers.

Authors:  Ather Muneer
Journal:  Psychiatry Investig       Date:  2015-11-20       Impact factor: 2.505

9.  Preservation of Gray Matter Volume in Early Stage of Bipolar Disorder: A Case for Early Intervention: Préservation du volume de matière grise au stade précoce du trouble bipolaire: un cas pour intervention précoce.

Authors:  Kamyar Keramatian; Wayne Su; Gayatri Saraf; Trisha Chakrabarty; Lakshmi N Yatham
Journal:  Can J Psychiatry       Date:  2020-05-18       Impact factor: 4.356

Review 10.  Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.

Authors:  Enrique L M Ochoa
Journal:  Cell Mol Neurobiol       Date:  2021-08-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.